Menu
GeneBe

GFM2

GTP dependent ribosome recycling factor mitochondrial 2

Basic information

Region (hg38): 5:74721205-74767147

Links

ENSG00000164347NCBI:84340OMIM:606544HGNC:29682Uniprot:Q969S9AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • combined oxidative phosphorylation deficiency 39 (Moderate), mode of inheritance: AR
  • combined oxidative phosphorylation deficiency 39 (Supportive), mode of inheritance: AR
  • combined oxidative phosphorylation deficiency 39 (Limited), mode of inheritance: AR
  • Leigh syndrome (Moderate), mode of inheritance: AR

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Combined oxidative phosphorylation deficiency 39ARGeneralGenetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testingBiochemical; Neurologic; Musculoskeletal22700954; 26016410; 29075935

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the GFM2 gene.

  • not provided (246 variants)
  • not specified (28 variants)
  • Inborn genetic diseases (28 variants)
  • Combined oxidative phosphorylation deficiency 39 (14 variants)
  • Sandhoff disease (6 variants)
  • Combined oxidative phosphorylation deficiency 39;Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 (2 variants)
  • Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1;Combined oxidative phosphorylation deficiency 39 (1 variants)
  • GFM2-related condition (1 variants)
  • Mitochondrial disease (1 variants)
  • See cases (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the GFM2 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
1
clinvar
31
clinvar
2
clinvar
34
missense
109
clinvar
11
clinvar
7
clinvar
127
nonsense
1
clinvar
8
clinvar
9
start loss
0
frameshift
1
clinvar
6
clinvar
7
inframe indel
3
clinvar
1
clinvar
4
splice donor/acceptor (+/-2bp)
1
clinvar
2
clinvar
2
clinvar
5
splice region
1
2
10
3
16
non coding
1
clinvar
42
clinvar
30
clinvar
73
Total 1 4 130 84 40

Highest pathogenic variant AF is 0.0000329

Variants in GFM2

This is a list of pathogenic ClinVar variants found in the GFM2 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
5-74721215-A-C Sandhoff disease Likely benign (Jan 13, 2018)354139
5-74721255-CTG-C Sandhoff disease Benign/Likely benign (Jan 15, 2024)354140
5-74721280-T-C Sandhoff disease Uncertain significance (Jan 12, 2018)354141
5-74721674-C-T not specified Benign (Jan 30, 2024)137480
5-74721681-G-A Uncertain significance (Nov 02, 2023)1949644
5-74721687-T-C Uncertain significance (Nov 27, 2023)1946531
5-74721698-T-C Uncertain significance (Jan 09, 2023)1963756
5-74721699-G-A Sandhoff disease Uncertain significance (Jan 06, 2017)549863
5-74721708-T-C Inborn genetic diseases Uncertain significance (Nov 28, 2023)1329540
5-74721747-A-AG not specified Uncertain significance (Aug 25, 2023)2581387
5-74721755-G-GT Sandhoff disease Uncertain significance (Apr 06, 2018)557797
5-74721764-C-T Inborn genetic diseases Uncertain significance (Oct 17, 2023)1698268
5-74721765-G-A Sandhoff disease Uncertain significance (Nov 28, 2017)555312
5-74721765-G-C not specified • GFM2-related disorder Benign (Jan 29, 2024)137479
5-74721774-T-G Uncertain significance (Feb 18, 2022)2099061
5-74721776-G-A Uncertain significance (Mar 13, 2023)2580023
5-74721782-C-T Conflicting classifications of pathogenicity (Dec 13, 2022)1320656
5-74721789-CA-C Benign (Jun 21, 2022)2006687
5-74721945-G-A Likely benign (Nov 27, 2018)1219640
5-74721983-T-C Likely benign (Jul 14, 2018)1188530
5-74722252-A-AAACTT Benign (Jun 19, 2018)1179243
5-74722378-C-T Uncertain significance (Nov 27, 2023)1440709
5-74722380-A-G Inborn genetic diseases Uncertain significance (Mar 04, 2024)3099458
5-74722384-T-C Combined oxidative phosphorylation deficiency 39 Uncertain significance (May 03, 2022)2442098
5-74722403-T-A Uncertain significance (Aug 19, 2022)2024684

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
GFM2protein_codingprotein_codingENST00000296805 2046168
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
1.49e-180.14512562601191257450.000473
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense0.7973634080.8890.00002035038
Missense in Polyphen136167.140.813712069
Synonymous1.771151420.8110.000006901509
Loss of Function1.353342.50.7770.00000232545

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.001310.00131
Ashkenazi Jewish0.0001040.0000992
East Asian0.0004410.000435
Finnish0.0001860.000185
European (Non-Finnish)0.0003920.000387
Middle Eastern0.0004410.000435
South Asian0.0005760.000555
Other0.001150.00114

dbNSFP

Source: dbNSFP

Function
FUNCTION: Mitochondrial GTPase that mediates the disassembly of ribosomes from messenger RNA at the termination of mitochondrial protein biosynthesis. Acts in collaboration with MRRF. GTP hydrolysis follows the ribosome disassembly and probably occurs on the ribosome large subunit. Not involved in the GTP-dependent ribosomal translocation step during translation elongation. {ECO:0000255|HAMAP-Rule:MF_03059, ECO:0000269|PubMed:19716793}.;
Pathway
Translation;Metabolism of proteins;Purine metabolism;Mitochondrial translation termination;Mitochondrial translation (Consensus)

Intolerance Scores

loftool
0.990
rvis_EVS
1.16
rvis_percentile_EVS
92.59

Haploinsufficiency Scores

pHI
0.136
hipred
N
hipred_score
0.426
ghis
0.535

Essentials

essential_gene_CRISPR
E
essential_gene_CRISPR2
E
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.875

Gene Damage Prediction

AllRecessiveDominant
MendelianHighHighHigh
Primary ImmunodeficiencyHighHighHigh
CancerHighHighHigh

Mouse Genome Informatics

Gene name
Gfm2
Phenotype

Gene ontology

Biological process
mitochondrial translation;ribosome disassembly;mitochondrial translational elongation;mitochondrial translational termination
Cellular component
mitochondrial matrix
Molecular function
translation elongation factor activity;GTPase activity;protein binding;GTP binding